ISCO

My pick for this qtr is International Stem Cell Corp (ISCO). I know we have talked about getting some biotech stocks into our portfolio in the past, but we concluded that we did not know enough about them to invest anything significant. My pick back at that meeting was Amylin which is actually up quite a bit right now (not that I knew that would happen). My rational for picking ISCO is that if we want to get in on the biotech, we might as well start small with stock with minimal risk and high potential for reward. Companies like ISCO are making some big breakthroughs in stem cell research and now that we don't have a Jesus freak in office, I think stem cell treatments will soon become common. This stock is cheap (around $2). I say we invest $50 - $75 and see what happens. A co-worker of mine picked up Biotime last year at a similar price, and its now up at $7 a share. Who knows if that will happen here, but its worth a shot. I like our odds here more than Tiger in the Masters. Its a gamble and we are Kenny Rogers. Below is an overview of the company. See you all on Sat.


International Stem Cell Corporation is a California-based biotechnology company focused on therapeutic and research products. ISCO’s core technology, parthenogenesis, results in creation of pluripotent human stem cells from unfertilized oocytes (eggs). hpSCs avoid ethical issues associated with the use or destruction of viable human embryos. ISCO scientists have created the first parthenogenetic, homozygous stem cell line that can be a source of immune-matched therapeutic cells to minimize immune rejection after transplantation into hundreds of millions of individuals of differing sexes, ages and racial groups. This offers the potential to create the first true stem cell bank, UniStemCell™, while avoiding the ethical issue of using fertilized eggs. ISCO also produces and markets specialized cells and growth media for therapeutic research worldwide through its subsidiary Lifeline Cell Technology. More information is available at ISCO’s website, www.internationalstemcell.com.